Q-linea and its distribution partners continue to advance pilot and tender process activities, which are leading indicators for future sales. ASTar is making progress in both US and Europe but sales cycles remains extended. The saving program is now in place and the cash position was SEK 20.5m, and this is extended to SEK81m when considering the credit facility from the main shareholder, Nexttobe.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking.www.redeye.se/